Naturally acquired Rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein

Naturally acquired Rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein

Rift Valley fever (RVF) is a viral hemorrhagic disease first discovered in Kenya in 1930. Numerous animal studies have demonstrated that protective immunity is acquired following RVF virus (RVFV) infection and that this correlates with acquisition of virus-neutralizing antibodies (nAbs) that target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wright, D, Allen, ER, Clark, MHA, Gitonga, JN, Karanja, HK, Hulswit, RJG, Taylor, I, Biswas, S, Marshall, J, Mwololo, D, Muriuki, J, Bett, B, Bowden, TA, Warimwe, GM
Formato:	Journal article
Lenguaje:	English
Publicado:	Cell Press 2020

Ejemplares similares

Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein
por: Daniel Wright, et al.
Publicado: (2020-11-01)

Rift Valley fever: biology and epidemiology
por: Wright, D, et al.
Publicado: (2019)

Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers.
por: Huiskonen, J, et al.
Publicado: (2009)

Two monoclonal antibodies against glycoprotein Gn protect mice from Rift Valley Fever challenge by cooperative effects.
por: Benjamin Gutjahr, et al.
Publicado: (2020-03-01)

Vaccine Efficacy of Self-Assembled Multimeric Protein Scaffold Particles Displaying the Glycoprotein Gn Head Domain of Rift Valley Fever Virus
por: Paul J. Wichgers Schreur, et al.
Publicado: (2021-03-01)

N-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN
por: Inaia Phoenix, et al.
Publicado: (2016-05-01)

Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein
por: Meng Hao, et al.
Publicado: (2020-02-01)

Association between Rift Valley fever virus seroprevalences in livestock and humans and their respective intra-cluster correlation coefficients, Tana River County, Kenya
por: Bett, B, et al.
Publicado: (2018)

What is the potential role of veterinary vaccination in the control of Rift Valley fever in Kenya?
por: Clark, MHA
Publicado: (2020)

A protective monoclonal antibody targets a site of vulnerability on the surface of Rift Valley fever virus
por: Allen, ER, et al.
Publicado: (2018)

Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.
por: Nitin Bhardwaj, et al.
Publicado: (2010-06-01)

Clinical manifestations of Rift Valley fever in humans: Systematic review and meta-analysis.
por: Zacchaeus Anywaine, et al.
Publicado: (2022-03-01)

Modelling Vaccination Strategies against Rift Valley Fever in Livestock in Kenya.
por: John M Gachohi, et al.
Publicado: (2016-12-01)

The Jordan Rift Valley /
por: 448285 Horowitz, Aharon
Publicado: (2001)

An XGBoost Approach to Predictive Modelling of Rift Valley Fever Outbreaks in Kenya Using Climatic Factors
por: Damaris Mulwa, et al.
Publicado: (2024-10-01)

Pastoralists' perceptions on the impact of Rift valley fever disease following an outbreak in North Eastern Kenya
por: Caroline M. Mburu, et al.
Publicado: (2022-06-01)

Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses
por: Nathaniel S. Chapman, et al.
Publicado: (2023-09-01)

Recent Advances in Bunyavirus Glycoprotein Research: Precursor Processing, Receptor Binding and Structure
por: Ruben J. G. Hulswit, et al.
Publicado: (2021-02-01)

Rift valley : Afro-Arabian /
por: Quennell, A. M.
Publicado: (1982)

The Pathogenesis of Rift Valley Fever
por: Tetsuro Ikegami, et al.
Publicado: (2011-05-01)

Rift Valley Fever Encephalitis
por: Abdulrahman A. Alrajhi, et al.
Publicado: (2004-03-01)

Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
por: Busquets, N, et al.
Publicado: (2014)

The Rift Valley fever accessory proteins NSm and P78/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts
por: Felix Kreher, et al.
Publicado: (2014-01-01)

Bacterium-Like Particles Displaying the Rift Valley Fever Virus Gn Head Protein Induces Efficacious Immune Responses in Immunized Mice
por: Shengnan Zhang, et al.
Publicado: (2022-03-01)

Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs
por: Busquets, N, et al.
Publicado: (2014)

Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein
por: Claudia Gandolfo, et al.
Publicado: (2021-08-01)

Fine epitope mapping of glycoprotein Gn in Guertu virus.
por: Jingyuan Zhang, et al.
Publicado: (2019-01-01)

A systematic review of Rift Valley Fever epidemiology 1931–2014
por: Mark O. Nanyingi, et al.
Publicado: (2015-07-01)

Systematic literature review of Rift Valley fever virus seroprevalence in livestock, wildlife and humans in Africa from 1968 to 2016
por: Clark, M, et al.
Publicado: (2018)

Spatial and temporal pattern of Rift Valley fever outbreaks in Tanzania; 1930 to 2007.
por: Calvin Sindato, et al.
Publicado: (2014-01-01)

Predictive Factors and Risk Mapping for Rift Valley Fever Epidemics in Kenya.
por: Peninah M Munyua, et al.
Publicado: (2016-01-01)

Seroepidemiology of Rift Valley Fever in Basrah
por: Rahman Kadhum Muhsen
Publicado: (2012-12-01)

An epidemiological model of Rift Valley fever
por: Nicole P. Leahy, et al.
Publicado: (2007-08-01)

Rift Valley fever: the Nigerian story
por: Adewale A. Adeyeye, et al.
Publicado: (2011-01-01)

Rift Valley fever: a review
por: Petrus Jansen van Vuren, et al.
Publicado: (2020-01-01)

Scientific Opinion on Rift Valley fever
por: EFSA Panel on Animal Health and Welfare (AHAW)
Publicado: (2013-04-01)

Rift Valley Fever in Goats, Cameroon
por: Matthew LeBreton, et al.
Publicado: (2006-04-01)

Genomic surveillance of Rift Valley fever virus: from sequencing to lineage assignment
por: John Juma, et al.
Publicado: (2022-07-01)

Dynamic risk model for Rift Valley fever outbreaks in Kenya based on climate and disease outbreak data
por: David Gikungu, et al.
Publicado: (2016-05-01)

Chimpanzee adenovirus vaccine provides multispecies protection against Rift Valley Fever
por: Warimwe, G, et al.
Publicado: (2016)